Aclarion Stock Probability Of Bankruptcy
| ACON Stock | USD 8.40 0.81 8.79% |
Aclarion |
Aclarion Company odds of distress Analysis
Aclarion's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current Aclarion Probability Of Bankruptcy | Over 85% |
Most of Aclarion's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aclarion is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Aclarion probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Aclarion odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Aclarion financial health.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aclarion. If investors know Aclarion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aclarion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aclarion is measured differently than its book value, which is the value of Aclarion that is recorded on the company's balance sheet. Investors also form their own opinion of Aclarion's value that differs from its market value or its book value, called intrinsic value, which is Aclarion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aclarion's market value can be influenced by many factors that don't directly affect Aclarion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aclarion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aclarion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aclarion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
| Competition |
Based on the latest financial disclosure, Aclarion has a Probability Of Bankruptcy of 85%. This is 96.35% higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 113.41% lower than that of the firm.
Aclarion Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aclarion's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aclarion could also be used in its relative valuation, which is a method of valuing Aclarion by comparing valuation metrics of similar companies.Aclarion is currently under evaluation in probability of bankruptcy category among its peers.
Aclarion Fundamentals
| Return On Equity | -7.14 | ||||
| Return On Asset | -1.15 | ||||
| Operating Margin | (103.51) % | ||||
| Current Valuation | 242.92 K | ||||
| Shares Outstanding | 69.31 K | ||||
| Shares Owned By Insiders | 9.76 % | ||||
| Shares Owned By Institutions | 3.58 % | ||||
| Number Of Shares Shorted | 7.75 M | ||||
| Price To Book | 0.25 X | ||||
| Price To Sales | 0.04 X | ||||
| Revenue | 75.4 K | ||||
| Gross Profit | (27.8 K) | ||||
| EBITDA | (4.14 M) | ||||
| Net Income | (4.91 M) | ||||
| Cash And Equivalents | 3.79 M | ||||
| Cash Per Share | 0.49 X | ||||
| Total Debt | 1.13 M | ||||
| Current Ratio | 3.18 X | ||||
| Book Value Per Share | (0.88) X | ||||
| Cash Flow From Operations | (3.65 M) | ||||
| Short Ratio | 0.77 X | ||||
| Earnings Per Share | (804.49) X | ||||
| Target Price | 435.5 | ||||
| Beta | 0.4 | ||||
| Market Capitalization | 1.91 K | ||||
| Total Asset | 2.46 M | ||||
| Retained Earnings | (44.28 M) | ||||
| Working Capital | (1.9 M) | ||||
| Net Asset | 2.46 M |
About Aclarion Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aclarion's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aclarion using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aclarion based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
When determining whether Aclarion is a strong investment it is important to analyze Aclarion's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aclarion's future performance. For an informed investment choice regarding Aclarion Stock, refer to the following important reports: Check out Aclarion Piotroski F Score and Aclarion Altman Z Score analysis. To learn how to invest in Aclarion Stock, please use our How to Invest in Aclarion guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aclarion. If investors know Aclarion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aclarion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aclarion is measured differently than its book value, which is the value of Aclarion that is recorded on the company's balance sheet. Investors also form their own opinion of Aclarion's value that differs from its market value or its book value, called intrinsic value, which is Aclarion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aclarion's market value can be influenced by many factors that don't directly affect Aclarion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aclarion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aclarion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aclarion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.